CONSTRUCTIVE BIOLOGY LIMITEDActive

Company number 13758641Private limited companyIncorporated 2021

Key figures

£47,985,975+44.8%
Net assets 2025
+148.1%
Average annual growth 2021/22–2025
020 m40 m60 m2021/222022/2320242025

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 m40 m60 m2021/222022/2320242025
Filed accounts2021/22–2025
2021/222022/2320242025
Turnover———10,779,441
Profit for the year———-525,382
Cash at bank and in hand2,232,1298,134,47131,361,37145,230,269
Total assets3,248,1349,387,94534,026,504—
Total liabilities104,624419,711896,840—
Net assets / total equity3,143,5108,968,23433,129,66447,985,975
Average number of employees3152846

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company during the financial year continued to be that of research and experimental development on biotechnology.

As described in the company's latest filed accounts.

Summary: CONSTRUCTIVE BIOLOGY LIMITED

Company

CONSTRUCTIVE BIOLOGY LIMITED is a private limited company registered with Companies House under company number 13758641. It was incorporated on 22 Nov 2021. Its status is active. The registered office is in London (WC1N). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Turnover was £10,779,441. Loss for the year was £525,382. Net assets were £47,985,975, up 44.8% on the previous year. Cash at bank and in hand was £45,230,269. The company had an average of 46 employees. Figures are available for 4 financial years (2021/22–2025).

Control and charges

The company has 7 current directors.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 23 Nov 2026.